A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors

Clinical trial NCT00756340 · COMPLETED

Trial details

NCT number: NCT00756340
Sponsor: St. Jude Children's Research Hospital
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent or Refractory Solid Tumors CNS Malignancies

Start date: 2008-07-01
Primary completion: 2015-09-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.